Abingdon, United Kingdom

Sara Garcia-Rates


 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Sara Garcia-Rates: Innovator in Neurodegenerative Disorders and Cancer Treatment

Introduction

Sara Garcia-Rates is a prominent inventor based in Abingdon, GB. She has made significant contributions to the fields of neurodegenerative disorders and cancer treatment. With a total of 4 patents to her name, her work is paving the way for innovative therapies and diagnostic methods.

Latest Patents

Among her latest patents, one focuses on modified peptides for use in treating neurodegenerative disorders. This invention relates specifically to novel peptides, peptidomimetics, compositions, therapies, and methods for treating conditions such as Alzheimer's disease. Another significant patent addresses cancer, particularly through novel pharmaceutical compositions, therapies, and methods for treating, preventing, or ameliorating cancer, especially metastatic disease. This invention also encompasses diagnostic and prognostic methods for cancer and metastatic disease, along with biomarkers for these conditions.

Career Highlights

Sara Garcia-Rates is currently associated with Neuro-bio Ltd, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving patient outcomes through scientific discovery and application.

Collaborations

Sara collaborates with notable colleagues, including Susan Adele Greenfield and Paul Morrill, who contribute to her research endeavors.

Conclusion

Sara Garcia-Rates is a trailblazer in the fields of neurodegenerative disorders and cancer treatment, with her innovative patents reflecting her dedication to advancing medical science. Her contributions are vital in the ongoing fight against these challenging health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…